Skip to search formSkip to main contentSkip to account menu

CGP 42700

Known as: Benzamide, N-(2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-1-oxo-2-(phenylmethyl)-9,13-epoxy-1H,9H-diindolo(1,2,3-gh:3',2',1'-lm)pyrrolo(3,4-j)(1,7)benzodiazonin-11-yl)-N-methyl-, (9alpha,10beta,11beta,13alpha)-, CGP-42700 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

AlkaloidsStaurosporine
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Reversal of multidrug resistance by the staurosporine derivatives CGP 41251 and CGP 42700
It has been shown previously that the staurosporine derivative CGP 41251, a specific inhibitor of protein kinase C (IC50 = 50 nM… 
1998
1998
Treatment of human glioblastoma cells with the staurosporine derivative CGP 41251 inhibits CDC2 and CDK2 kinase activity and increases radiation sensitivity.
CGP, 41251, a staurosporine derivative, is a potent inhibitor of protein kinase C (PKC). In recent studies we found that this… 
1996
1996
The role of protein kinase C in nicotinic responses of bovine chromaffin cells.
1993
1993
Effects of a new protein kinase C inhibitor CGP 41251 on T cell functions: inhibition of activation, growth, and target cell killing.
The effects of CGP 41251, a specific inhibitor of protein kinase C (PKC), its inactive derivative CGP 42700, and of staurosporine… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)